The invention relates to the discovery that nearly all medulloblastomas express neurotrophin-3 (NT-3) and its specific receptor TrkC. NT-3 was found to promote apoptosis in some medulloblastomas, therefore differing from the biologic actions most commonly described for neurotrophins. Based on these findings, the invention discloses methods of analyzing a medulloblastoma and for identifying molecules for treatment of medulloblastoma.
申请公布号
WO9940103(A1)
申请公布日期
1999.08.12
申请号
WO1999US02871
申请日期
1999.02.10
申请人
THE CHILDREN'S MEDICAL CENTER CORPORATION;POMEROY, SCOTT, L.;SEGAL, ROSALIND, A.